Atalanta Sosnoff Capital LLC lifted its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 138.5% in the 1st quarter, Holdings Channel reports. The firm owned 5,235 shares of the medical research company’s stock after buying an additional 3,040 shares during the quarter. Atalanta Sosnoff Capital LLC’s holdings in Thermo Fisher Scientific were worth $1,433,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Vanguard Group Inc. raised its position in Thermo Fisher Scientific by 1.2% in the third quarter. Vanguard Group Inc. now owns 29,271,095 shares of the medical research company’s stock worth $7,144,489,000 after acquiring an additional 347,836 shares in the last quarter. Vanguard Group Inc lifted its holdings in Thermo Fisher Scientific by 1.2% in the third quarter. Vanguard Group Inc now owns 29,271,095 shares of the medical research company’s stock valued at $7,144,489,000 after acquiring an additional 347,836 shares during the period. BlackRock Inc. lifted its holdings in Thermo Fisher Scientific by 3.7% in the fourth quarter. BlackRock Inc. now owns 26,177,278 shares of the medical research company’s stock valued at $5,858,214,000 after acquiring an additional 944,035 shares during the period. Oregon Public Employees Retirement Fund boosted its position in shares of Thermo Fisher Scientific by 44,296.5% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 19,565,960 shares of the medical research company’s stock worth $87,000 after purchasing an additional 19,521,889 shares in the last quarter. Finally, FMR LLC boosted its position in shares of Thermo Fisher Scientific by 33.4% during the 4th quarter. FMR LLC now owns 8,671,713 shares of the medical research company’s stock worth $1,940,642,000 after purchasing an additional 2,172,574 shares in the last quarter. 88.66% of the stock is owned by hedge funds and other institutional investors.

In related news, CFO Stephen Williamson sold 2,500 shares of the company’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $266.00, for a total value of $665,000.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Peter E. Hornstra sold 5,920 shares of the stock in a transaction on Friday, February 15th. The shares were sold at an average price of $250.00, for a total value of $1,480,000.00. Following the sale, the chief accounting officer now owns 17,057 shares in the company, valued at approximately $4,264,250. The disclosure for this sale can be found here. Insiders have sold a total of 36,927 shares of company stock valued at $9,388,124 over the last 90 days. 0.49% of the stock is currently owned by insiders.

A number of equities analysts have recently weighed in on the stock. Robert W. Baird upped their price target on shares of Thermo Fisher Scientific from $264.00 to $270.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 30th. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $310.00 price objective for the company in a research note on Tuesday. BTIG Research boosted their price objective on shares of Thermo Fisher Scientific to $310.00 and gave the stock a “buy” rating in a report on Tuesday, March 26th. Deutsche Bank boosted their price objective on shares of Thermo Fisher Scientific from $275.00 to $300.00 and gave the stock a “buy” rating in a report on Friday, March 22nd. Finally, UBS Group upped their target price on shares of Thermo Fisher Scientific to $305.00 and gave the stock a “buy” rating in a research report on Monday, March 25th. Two research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company’s stock. Thermo Fisher Scientific has an average rating of “Buy” and a consensus target price of $289.00.

Thermo Fisher Scientific stock opened at $277.80 on Wednesday. The company has a current ratio of 1.73, a quick ratio of 1.24 and a debt-to-equity ratio of 0.64. The firm has a market capitalization of $110.32 billion, a price-to-earnings ratio of 24.98, a PEG ratio of 1.82 and a beta of 1.13. Thermo Fisher Scientific Inc. has a fifty-two week low of $202.83 and a fifty-two week high of $279.61.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings results on Wednesday, January 30th. The medical research company reported $3.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.19 by $0.06. The business had revenue of $6.51 billion during the quarter, compared to the consensus estimate of $6.26 billion. Thermo Fisher Scientific had a return on equity of 16.86% and a net margin of 12.06%. The business’s revenue was up 7.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.79 EPS. Equities analysts predict that Thermo Fisher Scientific Inc. will post 12.15 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 16th. Shareholders of record on Friday, March 15th will be issued a dividend of $0.19 per share. This is an increase from Thermo Fisher Scientific’s previous quarterly dividend of $0.17. This represents a $0.76 annualized dividend and a yield of 0.27%. The ex-dividend date is Thursday, March 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 6.83%.

TRADEMARK VIOLATION NOTICE: This piece was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this piece can be viewed at https://www.watchlistnews.com/atalanta-sosnoff-capital-llc-has-1-43-million-stake-in-thermo-fisher-scientific-inc-tmo/2952040.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Featured Story: How a Strangle Strategy is different from a Straddle Strategy

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.